Head-to-head · Value Score
bmiMD vs Vaylen
Two GLP-1 deals, scored on the same six factors. bmiMD lands a Value Score of 89, Vaylen a 87. Here's who gives you the honest lower price — and where each one bites back.
bmiMD
#8 · Grade A · Great Deal
Est. first month
$99/mo
Save ~93% vs brand-nameVaylen
#13 · Grade A- · Great Deal
Est. first month
$179/mo
Save ~87% vs brand-nameThe verdict
bmiMD takes it on Value Score, 89 to 87 — an est. $99/mo first month, with no teaser step-up baked in. Vaylen isn't out of it: Shoppers who want maximum flexibility — compounded, brand, or oral — from one verified nationwide program.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | bmiMD | Vaylen |
|---|---|---|
| Value Score | 89 (A) | 87 (A-) |
| Est. first month | $99/mo | $179/mo |
| Save vs brand-name | ~93% | ~87% |
| Semaglutide | $99/mo | $179/mo |
| Tirzepatide | $139/mo | $239/mo |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Flat — no step-up |
| Coverage | All 50 states | All 50 states |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
bmiMD
Sub-$100 semaglutide and a low $139 tirzepatide, flat and nationwide — a straight-up low-price play.
Why it's a deal
- $99 flat semaglutide and a low $139 tirzepatide
- Available in all 50 states
- Both molecules priced up front
The fine print
- Not LegitScript-certified — do your own pharmacy diligence
- Thin public track record; no oral or brand-name option
Vaylen
The most complete menu in the mid-tier: flat pricing, brand-name access, an oral route, and a LegitScript pharmacy.
Why it's a deal
- LegitScript-certified with all-50-state reach
- Offers compounded, FDA-approved brand-name, and oral routes
- Flat $179 sema / $239 tirz — no teaser step-up
The fine print
- Pricing is mid-pack, not rock-bottom
- You pay for the breadth of options
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.